The recognition of DF (DHF Dengue Hemorrhagic Fever) is very complicated due to occurrence of a wide spectrum of clinical signs and symptoms during acute phase of illness. Moreover, presence of four serotypes further complicates the prognosis. To investigate the predictors of disease severity and elucidate the prognostic markers among four dengue serotypes, this study was conducted on 320 inpatients having acute febrile illness clinically suspected as DI, over a period of five years. Dengue serotypes were confirmed by multiplex reverse transcriptase (RT)-PCR. Eighty patients were positive for DI with presence of Den-1, Den-2, Den-3, and Den-4 in 8, 35, 27 and 10 patients, respectively. The severe clinical manifestations, abdominal pain and hepatomegaly, were comparatively higher in Den-2 patients. Liver aminotransferases levels were also higher in Den-2 patients (app. 5 fold). This study clearly indicates the hyperendemicity of all dengue serotypes. Nucleotide sequencing of Envelope region revealed that the presently emerged Den-3 belongs to type III, having high homology with genotype responsible for number of outbreaks in 1980s. The re-emergence of this deadly type can be suspected to cause more outbreaks in future and is a matter of great concern.
Journal Information
Vol. 14. Issue 2.
Pages 141-146 (March - April 2010)
Vol. 14. Issue 2.
Pages 141-146 (March - April 2010)
Original article
Open Access
Correlation of disease spectrum among four Dengue serotypes: a five years hospital based study from India
Visits
2966
Rajni Kumaria
Corresponding author
rankumaria@gmail.com
Correspondence to:Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore. Phone: 65 82282240.
Correspondence to:Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore. Phone: 65 82282240.
Postdoctoral Associate – Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore
This item has received
Article information
Abstract
Keywords:
Dengue fever
dengue infection
serotype
clinical spectra
liver transaminase
Full text is only aviable in PDF
References
[1.]
World Health Organization. Prevention and control of dengue and dengue hemorrhagic fever: comprehensive guidelines. WHO Regional publication, SEARO 1999; 29.
[2.]
D.J. Gubler.
Dengue and dengue hemorrhagic fever.
Clin Microbiol Rev, 11 (1998), pp. 480-496
[3.]
G.N. Malavige, S. Fernando, D.J. Fernando, S.L. Seneviratne.
Dengue viral infections.
Post Grad Med J, 80 (2004), pp. 588-601
[4.]
CDC; Centers for Disease Control and Prevention. National Center for Infectious Diseases, Division of Vector-Borne Infectious Diseases. Dengue fever home page year. www.cdc.gov/ncidod/dvbid/dengue.htm.
[5.]
Dengue Net-WHOs Internet-based System for Global Surveillance of Dengue Fever and Dengue Haemorrhagic Fever (Dengue / DHF). Weekly Epidemiological Record 2002; 77(36):301-304. http://www.who.int/denguenet.
[6.]
R.V. Gibbons, D.W. Vaughn.
Dengue: an escalating problem.
B M J, 324 (2002), pp. 1563-1566
[7.]
Sapir DG, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerging Themes in Epidemiology 2005, 2:1 doi:10.1186/1742-7622-2-1 online http://www.eteonline.com/content/2/1/1.
[8.]
T.P. Endy, A. Nisalak, S. Chunsuttiwat, et al.
Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand.
Am J Epidemiol, 56 (2002), pp. 52-59
[9.]
M.G. Guzman, G. Kouri.
Dengue and dengue hemorrhagic fever in Americas: lessons and challenges.
J Clin Virol, 27 (2003), pp. 1-13
[10.]
World Health Organization.
Dengue haemorrhagic fever: diagnosis, treatment, prevention and control.
2nd ed., World Health Organization, (1997),
[11.]
Dengue Net in India. Weekly Epidemiological Record 2004; 79(6):57-62.
[12.]
U.B. Singh, A. Maitra, S. Broor, A. Rai, S.T. Pasha, P. Seth.
Partial nucleotide sequencing and molecular evolution of epidemic causing dengue 2 strains.
J Infect Dis, 180 (1999), pp. 959-965
[13.]
R. Kumaria, A. Chakravarti.
Molecular detection and serotypic characterization of dengue viruses by single tube multiplex RT-PCR.
Diagn Microbiol Infect Dis, 52 (2005), pp. 311-316
[14.]
A. Balmaseda, S.N. Hammond, L. Pérez, et al.
Serotype-specific differences in clinical manifestations of dengue.
Am J Trop Med. Hyg, 74 (2006), pp. 449-456
[15.]
E. Harris, G. Roberts, L. Smith, et al.
Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR.
J Clin Microbiol, 36 (1998), pp. 2634-2639
[16.]
A. Igarashi.
Mosquito cell cultures and study of arthropodborne togaviruses.
Adv Virus Res, 30 (1985), pp. 21-39
[17.]
R.B. Tesh.
A method for the isolation and identification of dengue viruses, using mosquito cell cultures.
Am J Trop Med Hyg, 28 (1979), pp. 1053-1059
[18.]
A. Chakravarti, R. Kumaria, P. Kar, V.V. Batra, V. Verma.
Improved Detection of Dengue Virus Serotypes From Serum Samples-Evaluation of Single Tube Multiplex RT-PCR with Cell Culture.
WHO Dengue Bull, 30 (2006), pp. 133-140
[19.]
C. Domingo, G. Palacios, M. Niedrig, et al.
A New Tool for the Diagnosis and Molecular Surveillance of Dengue Infections in Clinical Samples.
WHO Dengue Bull, 28 (2004), pp. 87-95
[20.]
A. Chakravarti, R. Kumaria.
Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India.
Virology J, 2 (2005), pp. 1-7
[21.]
R.R. Graham, M. Juffrie, R. Tan, et al.
A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia Studies in 1995-1996.
Am J Trop Med Hyg, 61 (1999), pp. 412-419
[22.]
S. Kalayanarooj, S. Nimmannitya.
Clinical and laboratory presentations of dengue patients with different serotypes.
WHO Dengue Bulletin, 24 (2000), pp. 53-59
[23.]
D.W. Vaughn, S. Green, S. Kalayanarooj, et al.
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
J Infect Dis, 181 (2000), pp. 2-9
[24.]
A. Nisalak, T.P. Endy, S. Nimmanniya, et al.
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973-1979.
Am J Trop Med Hyg, 68 (2003), pp. 191-202
[25.]
A.L. Corwin, R.P. Larasati, M.J. Bangs, et al.
Epidemic dengue transmission in southern Sumatra, Indonesia.
Trans R Soc Trop Med Hyg, 95 (2001), pp. 257-265
[26.]
H.Y. Lei, T.M. Yeh, H.S. Liua, Y.S. Lin, S.H. Chen, C.C. Liu.
Immunopathogenesis of Dengue Virus Infection.
J Biomed Sci, 8 (2001), pp. 377-388
[27.]
Y.H. Huang, C.C. Liu, S.T. Wang, H.Y. Lei, H.L. Liu, Y.S. Lin.
Activation of coagulation and fibrinolysis during dengue virus infection.
J Med Virol, 63 (2001), pp. 247-251
[28.]
R.S. Lanciotti, J.L. Lewis, D.J. Gubler, D.W. Trent.
Molecular evolution and epidemiology of dengue-3 viruses.
J Gen Virol, 75 (1994), pp. 65-75
[29.]
C.N. Peyrefitte, P. Couissinier-Paris, V. Mercier-Perennec, et al.
Genetic Characterization of Newly Reintroduced Dengue Virus Type 3 in Martinique (French West Indies).
J Clin Microbio, 41 (2003), pp. 5195-5198
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved